Obligations for license holders of oral contraceptive products
On November 30, 2022, the Institute of Public Health has issued resolution No. 5250 that complements resolution No. 2198/2022 that established the obligations addressed to holders of oral contraceptive products, consisting of active tablets and placebos. Initially, Resolution No. 2198/2022 established that oral contraceptives consisting of active tablets and placebos must be made up of …
Obligations for license holders of oral contraceptive products Read More »